医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Health Insurance Premiums Have Decreased in a Number of Countries, According to Pacific Prime’s Latest Report

2021年02月23日 AM11:00
このエントリーをはてなブックマークに追加


 

HONG KONG

Global health insurance brokerage Pacific Prime’s latest report examines international private medical insurance (IPMI) premiums in 100 locations and finds that a number of locations’ IPMI premiums have decreased for both individuals and families. This is due to a number of key factors, chief of them being the unprecedented COVID-19 pandemic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210222005328/en/

Pacific Prime’s Cost of International Health Insurance Report 2020-2021 begins by ranking countries based on their average IPMI premiums. The US takes the number one spot, with average premiums of USD $7,703 for individuals and USD $21,817 for families. At the bottom end of the spectrum, Thailand had the cheapest average premiums of USD $1,934 for individuals and USD $7,257 for families.

From the 100 locations studied, up to 36 countries showed a decrease in IPMI premiums, compared with the previous year, as the COVID-19 pandemic has caused people to avoid/delay seeking healthcare treatment, and countries to impose lockdown measures. In addition to the overarching trend in IPMI premiums, the report also sheds light on region-specific trends including:

  • 12 out of 20 locations with the costliest health insurance premiums are located in the Americas. The US remained the country with the highest premiums due to its exorbitant cost of care, while Latin American countries’ premiums may see a jump in the next 5 years due to a rise in expensive claims for behavioral and mental health conditions.
  • Hong Kong has reclaimed its position as the second most expensive location in the world for health insurance. Similarly, Singapore is the second most expensive location in Asia. This is due to factors such as overutilization of health insurance and a rapidly aging population, amongst others.
  • China’s health insurance premiums are going through a correction phase after years of increase, as a result of sluggish demand amidst a global economic downturn. The country’s insurance landscape is also witnessing digitalization, as insurtech takes center stage.
  • Health insurance companies are beginning to refine and redefine their premium pricing strategy for each region to strike an optimal balance between service quality and operational sustainability, as well as to prepare for any crises that could arise in the near future.

Download a free copy of Pacific Prime’s Cost of International Health Insurance Report 2020-2021 to learn more about the aforementioned trends, as well as to contextualize them with the key drivers shaping health insurance including the changing demand for care, cost of care, increased regulation, continued challenges related to fraud, and the rise of insurtech.

About Pacific Prime:

Established in 1999, Pacific Prime is an award-winning insurance brokerage, operating out of its headquarters in Hong Kong and regional offices strategically located across Asia, the Middle East, Europe, and the Americas. The brokerage is dedicated to simplifying insurance for individuals, families, and corporates. To learn more, visit: https://www.pacificprime.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005328/en/

CONTACT

Stephen Ho, Marketing Director – Pacific Prime and Kwiksure

+852 3589 0508

同じカテゴリーの記事 

  • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market
  • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
  • Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China